Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose intravenous perampanel for prevention of early postoperative seizures after brain tumor surgery (poSTOP seizure-1 SF)
jRCTs031230730Completed
- Sponsor
- University of Tsukuba Hospital
- Start
- Apr 2024
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of perampanel in brain neoplasm and post-operative seizure (APOS), sponsored by University of Tsukuba Hospital. Primary endpoint: Incidence of CTCAE grade 3 or higher adverse events related to study drug. Started Apr 2024; status: completed.
02
Drugs
perampanel
03
Conditions
brain neoplasmpost-operative seizure (APOS)
Beyond the preview
Go deeper on jRCTs031230730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230730.